Format
Items per page
Sort by

Send to:

Choose Destination

Results: 10

References for PMC Articles for PubMed (Select 22139861)

1.

Impact of Huntington's across the entire disease spectrum: the phases and stages of disease from the patient perspective.

Ho AK, Hocaoglu MB; European Huntington's Disease Network Quality of Life Working Group.

Clin Genet. 2011 Sep;80(3):235-9. doi: 10.1111/j.1399-0004.2011.01748.x. Epub 2011 Aug 4.

2.

Observing Huntington's Disease: the European Huntington's Disease Network's REGISTRY.

Orth M, Handley OJ, Schwenke C, Dunnett SB, Craufurd D, Ho AK, Wild E, Tabrizi SJ, Landwehrmeyer GB; Investigators of the European Huntington's Disease Network.

Version 2. PLoS Curr. 2010 Sep 28 [revised 2011 Apr 13];2:RRN1184.

3.

Tetrabenazine as anti-chorea therapy in Huntington disease: an open-label continuation study. Huntington Study Group/TETRA-HD Investigators.

Frank S.

BMC Neurol. 2009 Dec 18;9:62. doi: 10.1186/1471-2377-9-62. Erratum in: BMC Neurol. 2011;11:18.

4.

Tetrabenazine.

Hayden MR, Leavitt BR, Yasothan U, Kirkpatrick P.

Nat Rev Drug Discov. 2009 Jan;8(1):17-8. doi: 10.1038/nrd2784. No abstract available.

PMID:
19116624
5.

Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial.

Huntington Study Group.

Neurology. 2006 Feb 14;66(3):366-72.

PMID:
16476934
6.

Depression: the case for a monoamine deficiency.

Delgado PL.

J Clin Psychiatry. 2000;61 Suppl 6:7-11. Review.

PMID:
10775018
7.

Long-term effects of tetrabenazine in hyperkinetic movement disorders.

Jankovic J, Beach J.

Neurology. 1997 Feb;48(2):358-62.

PMID:
9040721
8.

Dose-dependent inhibition of CYP1A2, CYP2C19 and CYP2D6 by citalopram, fluoxetine, fluvoxamine and paroxetine.

Jeppesen U, Gram LF, Vistisen K, Loft S, Poulsen HE, Brøsen K.

Eur J Clin Pharmacol. 1996;51(1):73-8.

PMID:
8880055
9.

Tetrabenazine-induced depletion of brain monoamines: characterization and interaction with selected antidepressants.

Pettibone DJ, Totaro JA, Pflueger AB.

Eur J Pharmacol. 1984 Jul 20;102(3-4):425-30.

PMID:
6489435
10.

Depletion of monoamine transmitters by tetrabenazine in brain tissue in Huntington's disease.

Pearson SJ, Reynolds GP.

Neuropharmacology. 1988 Jul;27(7):717-9.

PMID:
2901681
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk